CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $221 | +2.3% | 4,884 | +26.5% | 0.01% | +25.0% |
Q2 2023 | $216 | -7.7% | 3,861 | -25.5% | 0.00% | -20.0% |
Q1 2023 | $234 | +9.3% | 5,180 | -1.9% | 0.01% | 0.0% |
Q4 2022 | $214 | -100.0% | 5,280 | -34.8% | 0.01% | -66.7% |
Q3 2022 | $528,000 | +417.6% | 8,092 | +381.7% | 0.02% | +400.0% |
Q2 2022 | $102,000 | -25.0% | 1,680 | -22.5% | 0.00% | 0.0% |
Q1 2022 | $136,000 | +172.0% | 2,168 | +262.5% | 0.00% | +50.0% |
Q3 2020 | $50,000 | – | 598 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |